These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 17060898

  • 21. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2005 Aug; 116(2):496-505. PubMed ID: 15995007
    [Abstract] [Full Text] [Related]

  • 22. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.
    Souayah N, Yacoub HA, Khan HM, Farhad K, Maybodi L, Qureshi AI, Menkes DL.
    J Clin Neurosci; 2012 Aug; 19(8):1089-92. PubMed ID: 22705140
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.
    McMahon AW, Eidex RB, Marfin AA, Russell M, Sejvar JJ, Markoff L, Hayes EB, Chen RT, Ball R, Braun MM, Cetron M, Yellow Fever Working Group.
    Vaccine; 2007 Feb 26; 25(10):1727-34. PubMed ID: 17240001
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K.
    Arch Intern Med; 2006 Nov 13; 166(20):2217-21. PubMed ID: 17101939
    [Abstract] [Full Text] [Related]

  • 33. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S, Ball R, Braun MM.
    Vaccine; 2008 May 02; 26(19):2428-32. PubMed ID: 18406499
    [Abstract] [Full Text] [Related]

  • 34. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.
    Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N.
    JAMA; 2021 Oct 26; 326(16):1606-1613. PubMed ID: 34617967
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).
    Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 May 02; 57(17):462-5. PubMed ID: 18451758
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
    Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT.
    N Engl J Med; 1998 Dec 17; 339(25):1797-802. PubMed ID: 9854114
    [Abstract] [Full Text] [Related]

  • 40. Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007.
    Lu PJ, Jain N, Cohn AC.
    Vaccine; 2010 Mar 08; 28(11):2350-5. PubMed ID: 20044055
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.